These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 37816055)
1. Targeting MFGE8 secreted by cancer-associated fibroblasts blocks angiogenesis and metastasis in esophageal squamous cell carcinoma. Liu B; Zhang B; Qi J; Zhou H; Tan L; Huang J; Huang J; Fang X; Gong L; Luo J; Liu S; Fu L; Ling F; Ma S; Lai-Wan Kwong D; Wang X; Guan XY Proc Natl Acad Sci U S A; 2023 Oct; 120(42):e2307914120. PubMed ID: 37816055 [TBL] [Abstract][Full Text] [Related]
2. Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma. Tian B; Chen X; Zhang H; Li X; Wang J; Han W; Zhang LY; Fu L; Li Y; Nie C; Zhao Y; Tan X; Wang H; Guan XY; Hong A Oncotarget; 2017 Jun; 8(26):42300-42313. PubMed ID: 28404945 [TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblasts-derived exosomal miR-3656 promotes the development and progression of esophageal squamous cell carcinoma via the ACAP2/PI3K-AKT signaling pathway. Jin Y; Meng Q; Zhang B; Xie C; Chen X; Tian B; Wang J; Shih TC; Zhang Y; Cao J; Yang Y; Chen S; Guan X; Chen X; Hong A Int J Biol Sci; 2021; 17(14):3689-3701. PubMed ID: 34671193 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-100-5p in cancer-associated fibroblast-derived exosomes facilitates lymphangiogenesis in esophageal squamous cell carcinoma. Chen C; Yang C; Tian X; Liang Y; Wang S; Wang X; Shou Y; Li H; Xiao Q; Shu J; Sun M; Chen K Cancer Med; 2023 Jul; 12(13):14468-14483. PubMed ID: 37184125 [TBL] [Abstract][Full Text] [Related]
5. HIC-5 in cancer-associated fibroblasts contributes to esophageal squamous cell carcinoma progression. Du X; Xu Q; Pan D; Xu D; Niu B; Hong W; Zhang R; Li X; Chen S Cell Death Dis; 2019 Nov; 10(12):873. PubMed ID: 31740661 [TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of FGFR2 Qiu H; Zhang X; Qi J; Zhang J; Tong Y; Li L; Fu L; Qin YR; Guan X; Zhang L J Exp Clin Cancer Res; 2022 Aug; 41(1):240. PubMed ID: 35941662 [TBL] [Abstract][Full Text] [Related]
7. Periostin in Cancer-Associated Fibroblasts Promotes Esophageal Squamous Cell Carcinoma Progression by Enhancing Cancer and Stromal Cell Migration. Miyako S; Koma YI; Nakanishi T; Tsukamoto S; Yamanaka K; Ishihara N; Azumi Y; Urakami S; Shimizu M; Kodama T; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H Am J Pathol; 2024 May; 194(5):828-848. PubMed ID: 38320632 [TBL] [Abstract][Full Text] [Related]
8. Emerging role of cancer-associated fibroblasts in esophageal squamous cell carcinoma. Li W; Xu T; Jin H; Li M; Jia Q Pathol Res Pract; 2024 Jan; 253():155002. PubMed ID: 38056131 [TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts mediated chemoresistance by a FOXO1/TGFβ1 signaling loop in esophageal squamous cell carcinoma. Zhang H; Xie C; Yue J; Jiang Z; Zhou R; Xie R; Wang Y; Wu S Mol Carcinog; 2017 Mar; 56(3):1150-1163. PubMed ID: 27769097 [TBL] [Abstract][Full Text] [Related]
10. Tumor-Derived CCL5 Recruits Cancer-Associated Fibroblasts and Promotes Tumor Cell Proliferation in Esophageal Squamous Cell Carcinoma. Dunbar KJ; Karakasheva TA; Tang Q; Efe G; Lin EW; Harris M; Sahu V; Sachdeva UM; Hu J; Klein-Szanto AJ; Henick B; Diehl JA; Nakagawa H; Rustgi AK Mol Cancer Res; 2023 Jul; 21(7):741-752. PubMed ID: 37027010 [TBL] [Abstract][Full Text] [Related]
11. Cancer-associated fibroblasts: An emerging target against esophageal squamous cell carcinoma. Qiu L; Yue J; Ding L; Yin Z; Zhang K; Zhang H Cancer Lett; 2022 Oct; 546():215860. PubMed ID: 35948121 [TBL] [Abstract][Full Text] [Related]
12. Rocuronium bromide suppresses esophageal cancer via blocking the secretion of C-X-C motif chemokine ligand 12 from cancer associated fibroblasts. Li J; Gu X; Wan G; Wang Y; Chen K; Chen Q; Lu C J Transl Med; 2023 Apr; 21(1):248. PubMed ID: 37029408 [TBL] [Abstract][Full Text] [Related]
13. Exosomal Sonic Hedgehog derived from cancer-associated fibroblasts promotes proliferation and migration of esophageal squamous cell carcinoma. Zhao G; Li H; Guo Q; Zhou A; Wang X; Li P; Zhang S Cancer Med; 2020 Apr; 9(7):2500-2513. PubMed ID: 32030915 [TBL] [Abstract][Full Text] [Related]
14. CAF-derived exosomes deliver LINC01410 to promote epithelial-mesenchymal transition of esophageal squamous cell carcinoma. Shi Z; Jiang T; Cao B; Sun X; Liu J Exp Cell Res; 2022 Mar; 412(2):113033. PubMed ID: 35041823 [TBL] [Abstract][Full Text] [Related]
15. Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma. Zhao Q; Huang L; Qin G; Qiao Y; Ren F; Shen C; Wang S; Liu S; Lian J; Wang D; Yu W; Zhang Y Cancer Lett; 2021 Oct; 518():35-48. PubMed ID: 34139285 [TBL] [Abstract][Full Text] [Related]
16. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma. Higashino N; Koma YI; Hosono M; Takase N; Okamoto M; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H Lab Invest; 2019 Jun; 99(6):777-792. PubMed ID: 30683902 [TBL] [Abstract][Full Text] [Related]
17. Hsa_circ_0023984 Regulates Cell Proliferation, Migration, and Invasion in Esophageal Squamous Cancer via Regulating miR-1294/PI3K/Akt/c-Myc Pathway. Liang W; Wang C; Wang J; Zhang M Appl Biochem Biotechnol; 2022 Sep; 194(9):1-16. PubMed ID: 35522362 [TBL] [Abstract][Full Text] [Related]
18. PAI-1 derived from cancer-associated fibroblasts in esophageal squamous cell carcinoma promotes the invasion of cancer cells and the migration of macrophages. Sakamoto H; Koma YI; Higashino N; Kodama T; Tanigawa K; Shimizu M; Fujikawa M; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H Lab Invest; 2021 Mar; 101(3):353-368. PubMed ID: 33311557 [TBL] [Abstract][Full Text] [Related]
19. Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance. Che Y; Wang J; Li Y; Lu Z; Huang J; Sun S; Mao S; Lei Y; Zang R; Sun N; He J Cell Death Dis; 2018 Jul; 9(7):759. PubMed ID: 29988148 [TBL] [Abstract][Full Text] [Related]
20. CAF-secreted CXCL1 conferred radioresistance by regulating DNA damage response in a ROS-dependent manner in esophageal squamous cell carcinoma. Zhang H; Yue J; Jiang Z; Zhou R; Xie R; Xu Y; Wu S Cell Death Dis; 2017 May; 8(5):e2790. PubMed ID: 28518141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]